InStride Health's Series B: A $30m Boost for Pediatric Mental Health
InStride Health, a pioneering provider of pediatric anxiety and Obsessive Compulsive Disorder (OCD) treatments, has secured a monumental $30M in Series B funding. Under CEO John Voith's leadership,...
